127556-98-3Relevant articles and documents
1,3-Benzodioxole-based fibrate derivatives as potential hypolipidemic and hepatoprotective agents
Bian, Xiao-Li,Liu, Ji-Ping,Shi, Yong-Heng,Sun, Meng,Wang, Bin,Wang, Wei,Wang, Xiao-Ping,Xie, Yun-Dong,Xu, Xin-Ya,Xu, Yan-Hong
supporting information, (2021/05/04)
A series of target compounds 1,3-benzodioxole-based fibrate derivatives were designed and synthesized. All the target compounds were preliminarily evaluated by hyperlipidemia mice induced by Triton WR-1339, in which compound 12 displayed a greater anti-hyperlipidemia activity than other compounds as well as positive drug fenofibrate (FF). 12 showed a significant reduction of plasma lipids, such as triglycerides (TG), total cholesterol (TC) and low-density lipoprotein cholesterin (LDL-C), in high fat diet (HFD) induced hyperlipidemic mice. In addition, hepatic transaminases (AST and ALT) were ameliorated after administration of 12, in particular the AST, and the histopathological examination showed that 12 improved the hepatic lipid accumulation. The expression of PPAR-α involved in lipids metabolism was up-regulated in the liver tissues of 12-treated group. Other significant activity such as antioxidant, and anti-inflammation was confirmed and reinforced the effects of 12 as a potential hypolipidemia and hepatoprotective agent.
The Preparation of 3,4-Dihydro-1-benzoxepin-5(2H)-ones
Freedman, Jules,Stewart, Kenneth T.
, p. 1547 - 1554 (2007/10/02)
Several methods for the preparation of 3,4-dihydro-1-benzoxepin-5(2H)-ones are described.In addition to the desired ketones, a veriety of novel by-products have been isolated.
